Familial amyloidosis surgery

Jump to navigation Jump to search

Familial amyloidosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Familial amyloidosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Familial amyloidosis surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Familial amyloidosis surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Familial amyloidosis surgery

CDC on Familial amyloidosis surgery

Familial amyloidosis surgery in the news

Blogs on Familial amyloidosis surgery

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Familial amyloidosis surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.

Overview

Organ-specific transplant may need to be done, depending on the organ involved. However, surgery is not commonly done in patients with amyloidosis, since it is usually a systemic disease that requires treatment of the underlying cause.

Indications

The mainstay of treatment for familial amyloidosis is eradicating the underlying cause. Surgery is usually reserved for patients with organ failure such as:[1]

  • Heart failure
  • Chronic renal disease
  • Liver failure

Surgery

References

  1. Estep JD, Bhimaraj A, Cordero-Reyes AM, Bruckner B, Loebe M, Torre-Amione G (2012). "Heart transplantation and end-stage cardiac amyloidosis: a review and approach to evaluation and management". Methodist Debakey Cardiovasc J. 8 (3): 8–16. PMC 3487570. PMID 23227279.

Template:WS Template:WH